Cargando…

Arthritis Interception in Patients with Psoriasis Treated with Guselkumab

Detalles Bibliográficos
Autores principales: Zabotti, Alen, Giovannini, Ivan, McGonagle, Dennis, De Vita, Salvatore, Stinco, Giuseppe, Errichetti, Enzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776915/
https://www.ncbi.nlm.nih.gov/pubmed/34837168
http://dx.doi.org/10.1007/s13555-021-00650-5
_version_ 1784636941657964544
author Zabotti, Alen
Giovannini, Ivan
McGonagle, Dennis
De Vita, Salvatore
Stinco, Giuseppe
Errichetti, Enzo
author_facet Zabotti, Alen
Giovannini, Ivan
McGonagle, Dennis
De Vita, Salvatore
Stinco, Giuseppe
Errichetti, Enzo
author_sort Zabotti, Alen
collection PubMed
description
format Online
Article
Text
id pubmed-8776915
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-87769152022-02-02 Arthritis Interception in Patients with Psoriasis Treated with Guselkumab Zabotti, Alen Giovannini, Ivan McGonagle, Dennis De Vita, Salvatore Stinco, Giuseppe Errichetti, Enzo Dermatol Ther (Heidelb) Commentary Springer Healthcare 2021-11-27 /pmc/articles/PMC8776915/ /pubmed/34837168 http://dx.doi.org/10.1007/s13555-021-00650-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Commentary
Zabotti, Alen
Giovannini, Ivan
McGonagle, Dennis
De Vita, Salvatore
Stinco, Giuseppe
Errichetti, Enzo
Arthritis Interception in Patients with Psoriasis Treated with Guselkumab
title Arthritis Interception in Patients with Psoriasis Treated with Guselkumab
title_full Arthritis Interception in Patients with Psoriasis Treated with Guselkumab
title_fullStr Arthritis Interception in Patients with Psoriasis Treated with Guselkumab
title_full_unstemmed Arthritis Interception in Patients with Psoriasis Treated with Guselkumab
title_short Arthritis Interception in Patients with Psoriasis Treated with Guselkumab
title_sort arthritis interception in patients with psoriasis treated with guselkumab
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776915/
https://www.ncbi.nlm.nih.gov/pubmed/34837168
http://dx.doi.org/10.1007/s13555-021-00650-5
work_keys_str_mv AT zabottialen arthritisinterceptioninpatientswithpsoriasistreatedwithguselkumab
AT giovanniniivan arthritisinterceptioninpatientswithpsoriasistreatedwithguselkumab
AT mcgonagledennis arthritisinterceptioninpatientswithpsoriasistreatedwithguselkumab
AT devitasalvatore arthritisinterceptioninpatientswithpsoriasistreatedwithguselkumab
AT stincogiuseppe arthritisinterceptioninpatientswithpsoriasistreatedwithguselkumab
AT errichettienzo arthritisinterceptioninpatientswithpsoriasistreatedwithguselkumab